NEWS & PERSPECTIVES
Psychedelics News
Curated updates on microdosing, research, policy, and community.
The latest
Study: OCD symptoms and hallucinogenic drugs.
Research Project Title: Exploring the impact of hallucinogenic drugs on OCD related symptoms. Chief Investigator: Dr Vince Polito Associate Investigators: Professor Melissa Norberg, Dr Christina Perry, Ms Dora Szabo
Women’s Health and Psychedelics – New Insights
Using validated behavior models and known standards, studies are finding significant differences between male and female rodents given psychedelic drugs.
Psilocybin generates psychedelic experience by disrupting brain network
Researchers report that psilocybin, the active ingredient in magic mushrooms, destabilizes a critical network of brain areas involved in introspective thinking. The findings provide a neurobiological explanation for t...
Psymposia’s Response to Heroic Hearts’ Pharma-Backed Press Conference
Veterans deserve the highest quality treatment for PTSD. It’s unacceptable and dangerous to use veterans as guinea pigs for a big pharma profit grab without resolving safety and efficacy concerns. The post Psymposia’...
Two new species of Psilocybe mushrooms discovered in southern Africa
In a new paper, researchers and citizen mycologists describe the two new species as Psilocybe ingeli and Psilocybe maluti. The paper also contains information on the traditional use of P. maluti by Basotho traditional...
Two reasons I’m sceptical about psychedelic science
There are fundamental flaws in psychedelics research. But I’m still intrigued by their potential.
Ketamine slow-release tablet reduces symptoms of severe depression: Clinical trial
A slow-release, tablet form of ketamine with minimal side-effects has the potential to make treatment more affordable and accessible.
Can LSD confer psychological strength and resilience?
Lifetime LSD use is associated with a higher likelihood of severe psychological distress after losing one's job, according to a new study.
Unregulated sales of a toxic and hallucinogenic mushroom endanger public health
Americans' interest in a potentially harmful 'magic mushroom' is soaring, according to a new study. The scientists suggest that the growing market for Amanita muscaria may be sparked in part by emerging clinical resea...
New understanding of how antidepressants work
Researchers have established a new framework for understanding how classic antidepressants work in treating major depressive disorder (MDD), reemphasizing their importance and aiming to reframe clinical conversation a...
Psychedelic drug-induced hyperconnectivity in the brain helps clarify altered subjective experiences
A new study shows that the use of psilocybin, a compound found in the widely known 'magic mushrooms,' initiates a pattern of hyperconnectivity in the brain linked to the ego-modifying effects and feelings of oceanic b...
How cannabis and psilocybin might help some of the 50 million Americans who are experiencing chronic pain
Cannabis and psilocybin – used under supervision – have the potential to work better than current pain treatments, but the research into both has long been hindered by federal legislation.
How psychedelic drugs interact with serotonin receptors to potentially produce therapeutic benefits
Researchers have shed valuable light on the complex mechanisms by which a class of psychedelic drugs binds to and activates serotonin receptors to produce potential therapeutic effects in patients with neuropsychiatri...
'Mathematical microscope' reveals novel, energy-efficient mechanism of working memory that works even during sleep
Researchers have discovered a mechanism that creates memories while reducing metabolic cost, even during sleep. This efficient memory occurs in a part of the brain that is crucial for learning and memory, and where Al...